Peggy Pui-Kay Ho

Title: Peggy Pui-Kay Ho: Innovator in Gene Therapy and Rheumatoid Arthritis Diagnosis

Introduction

Peggy Pui-Kay Ho is a prominent inventor based in Cupertino, CA. She has made significant contributions to the fields of gene therapy and rheumatoid arthritis diagnosis. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

One of her latest patents is titled "Replacement gene tolerizing vectors and methods of use thereof." This patent provides innovative vectors and methods for treating individuals undergoing gene therapy for muscular dystrophy, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). The methods involve administering a gene therapy tolerizing vaccine composition that includes a replacement gene tolerizing vector. This approach aims to reduce symptoms of the immune response to gene therapy and improve its efficacy.

Another significant patent is "Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis." This patent offers compositions and methods for classifying rheumatoid arthritis patients into subtypes. These subtypes are crucial for determining the patient's need for therapy and their responsiveness to specific treatments.

Career Highlights

Peggy Ho is affiliated with Leland Stanford Junior University, where she continues her research and innovation in the medical field. Her work has garnered attention for its potential to improve patient outcomes in gene therapy and rheumatoid arthritis treatment.

Collaborations

She has collaborated with notable colleagues, including Lawrence Steinman and William H. Robinson. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Peggy Pui-Kay Ho is a trailblazer in the realm of medical innovations, particularly in gene therapy and rheumatoid arthritis diagnosis. Her patents reflect her commitment to advancing healthcare solutions and improving the lives of patients.